Financhill
Sell
33

ADUS Quote, Financials, Valuation and Earnings

Last price:
$109.83
Seasonality move :
5.41%
Day range:
$108.78 - $112.01
52-week range:
$88.96 - $134.64
Dividend yield:
0%
P/E ratio:
23.62x
P/S ratio:
1.50x
P/B ratio:
1.94x
Volume:
144.2K
Avg. volume:
159.1K
1-year change:
-16.8%
Market cap:
$2B
Revenue:
$1.2B
EPS (TTM):
$4.67

Analysts' Opinion

  • Consensus Rating
    Addus HomeCare Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $141.00, Addus HomeCare Corp. has an estimated upside of 27.75% from its current price of $110.37.
  • Price Target Downside
    According to analysts, the lowest downside price target is $117.00 representing -6.01% downside risk from its current price of $110.37.

Fair Value

  • According to the consensus of 10 analysts, Addus HomeCare Corp. has 27.75% upside to fair value with a price target of $141.00 per share.

ADUS vs. S&P 500

  • Over the past 5 trading days, Addus HomeCare Corp. has overperformed the S&P 500 by 0.31% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Addus HomeCare Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Addus HomeCare Corp. has grown year-over-year revenues for 52 quarters straight. In the most recent quarter Addus HomeCare Corp. reported revenues of $362.3M.

Earnings Growth

  • Addus HomeCare Corp. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Addus HomeCare Corp. reported earnings per share of $1.24.
Enterprise value:
2.1B
EV / Invested capital:
--
Price / LTM sales:
1.50x
EV / EBIT:
15.71x
EV / Revenue:
1.59x
PEG ratio (5yr expected):
3.39x
EV / Free cash flow:
22.20x
Price / Operating cash flow:
20.99x
Enterprise value / EBITDA:
14.10x
Gross Profit (TTM):
$424.3M
Return On Assets:
6.25%
Net Income Margin (TTM):
6.36%
Return On Equity:
8.59%
Return On Invested Capital:
7.16%
Operating Margin:
9.09%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $1B $1.1B $1.3B $289.8M $362.3M
Gross Profit $315.2M $353.5M $424.3M $88.8M $112.3M
Operating Income $89.7M $105.7M $136.3M $26M $32.9M
EBITDA $103.6M $119.7M $151.8M $29.4M $37.3M
Diluted EPS $3.54 $4.37 $4.67 $1.10 $1.24
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $299.7M $240.1M $211.2M $332.8M $260.7M
Total Assets $924.9M $945.9M $1B $1.2B $1.4B
Current Liabilities $112.5M $128.2M $139.6M $157.8M $156.8M
Total Liabilities $366.9M $331.1M $351.4M $205.3M $373M
Total Equity $558.1M $614.8M $684.3M $947.6M $1B
Total Debt $263.9M $200.7M $205.5M $38.6M $189.5M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $106.5M $136.1M $103.2M $48.5M $51.3M
Cash From Investing -$133.2M -$5.4M -$376.9M -$1.9M -$22.8M
Cash From Financing $786K $12.5M $152.8M $2.9M -$17.8M
Free Cash Flow $96.9M $126.4M $96.4M $46.6M $49.4M
ADUS
Sector
Market Cap
$2B
$26M
Price % of 52-Week High
81.97%
51.81%
Dividend Yield
0%
0%
Shareholder Yield
-1.49%
-1.66%
1-Year Price Total Return
-16.8%
-18.29%
Beta (5-Year)
0.919
0.485
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $109.70
200-day SMA
Sell
Level $111.77
Bollinger Bands (100)
Sell
Level 110.03 - 117.85
Chaikin Money Flow
Buy
Level 13.3M
20-day SMA
Buy
Level $110.26
Relative Strength Index (RSI14)
Sell
Level 48.60
ADX Line
Sell
Level 14.43
Williams %R
Neutral
Level -40.8935
50-day SMA
Sell
Level $112.51
MACD (12, 26)
Sell
Level -1.02
25-day Aroon Oscillator
Sell
Level -44
On Balance Volume
Neutral
Level 19.2M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.2581)
Buy
CA Score (Annual)
Level (1.1168)
Buy
Beneish M-Score (Annual)
Level (-2.5185)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.1674)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded 1979 and is headquartered in Frisco, TX.

Stock Forecast FAQ

In the current month, ADUS has received 9 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ADUS average analyst price target in the past 3 months is $141.00.

  • Where Will Addus HomeCare Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Addus HomeCare Corp. share price will rise to $141.00 per share over the next 12 months.

  • What Do Analysts Say About Addus HomeCare Corp.?

    Analysts are divided on their view about Addus HomeCare Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Addus HomeCare Corp. is a Sell and believe this share price will drop from its current level to $117.00.

  • What Is Addus HomeCare Corp.'s Price Target?

    The price target for Addus HomeCare Corp. over the next 1-year time period is forecast to be $141.00 according to 10 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is ADUS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Addus HomeCare Corp. is a Buy. 9 of 10 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of ADUS?

    You can purchase shares of Addus HomeCare Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Addus HomeCare Corp. shares.

  • What Is The Addus HomeCare Corp. Share Price Today?

    Addus HomeCare Corp. was last trading at $109.83 per share. This represents the most recent stock quote for Addus HomeCare Corp.. Yesterday, Addus HomeCare Corp. closed at $110.37 per share.

  • How To Buy Addus HomeCare Corp. Stock Online?

    In order to purchase Addus HomeCare Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoundHound AI Stock Go Up?
Why Did SoundHound AI Stock Go Up?

SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…

Is Goldman Sachs Going to Go Up?
Is Goldman Sachs Going to Go Up?

Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…

How High Will MSTR Stock Go?
How High Will MSTR Stock Go?

After several months of pressure, shares of Bitcoin treasury Strategy…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
48
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
69
INTC alert for Jan 23

Intel Corp. [INTC] is down 17.01% over the past day.

Buy
70
BNR alert for Jan 23

Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.

Buy
80
MTRN alert for Jan 23

Materion Corp. [MTRN] is down 9.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock